Simplified Chinese
Tender Notice for the Supply and Installation of Elevators for the Minhai Biotechnology New‑Type Vaccine International Industrial Base Construction Project
Release date:
2020-11-02
Author:
Source:
Abstract
I. Project Name Minhai Biotechnology’s New Vaccine International Industrial Base Construction Project
II. Project Overview:
The Minhai Biologics International Vaccine Industrial Base Project, invested in and constructed by Beijing Minhai Biotechnology Co., Ltd., is located at Plot 0503-039 within the Daxing Biomedical Industry Base. Plots 040, 043, and 044 are bounded as follows: to the north by Simiao Road; to the south by the planned land‑use boundary (municipal green space); to the west by Xiangrui Avenue; and to the east by Tianfu Avenue. The project is primarily intended for the research, development, and production of human vaccines.
1. Construction scale: Total land area: 90,013.218 m² 2 , with a total floor area of 187,684.83 m² 2 (Of which, the above-ground floor area is 130,410.84 m²) 2 , underground floor area 57,273.99 m² 2 ). The building has a height of 33.3 meters, with one basement level and seven above-ground floors. The basement floor-to-floor height is 6 meters, while the above-ground floors range from 3.8 to 7.9 meters in height. The site coverage ratio is 15%, the floor area ratio is 1.5, and the building density is 40%.
2. Single-building structure: 1 Number R&D Pilot-Scale Building, 2 Building No. 1: R&D Technology Building; Building No. 3: Comprehensive Service Building; Building No. 4: Laboratory Animal Facility; Building No. 5: Hazardous Waste and Dangerous Goods Storage; Building No. 6: Wastewater Treatment Station; Building No. 7: Boiler Room; Building No. 8: Vaccine Production Building; Building No. 9: Packaging and Warehousing Building; Building No. 10: Bacterial Vaccine Production Building; Building No. 12: Basement; Building No. 13: Gatehouse; Building No. 14: Gatehouse; Building No. 15: Gatehouse.
3. Planned duration of the elevator project : 2021 March 2021 – December 2021.
4. Lead Design Institute: China Aviation Planning and Design Research Institute Co., Ltd.
III. Scope of the Tender:
The scope of this tender is the procurement and installation of elevators for the Minhai Biotechnology New‑Generation Vaccine International Industrial Base Project, including:
1. Detailed design of the elevator shaft;
2. The processing, manufacturing, installation, commissioning, acceptance, and maintenance of the vertical elevator total 26. Tai Direct Elevator (specific model numbers are listed in the table below);
| Building number |
Model number |
Number of stops |
Quantity |
Note |
| 1 Building No. |
DT1 |
7 |
1 |
Machine-room freight elevator |
| DT2 |
7 |
1 |
Elevator for the machine room |
|
| DT3 |
7 |
1 |
Machine-room freight elevator |
|
| DT4 |
7 |
1 |
Elevator for the machine room |
|
| DT5 |
7 |
1 |
Elevator for the machine room |
|
| 2 Building No. |
DT1 |
8 |
1 |
Machine-room‑less passenger elevator |
| DT2 |
8 |
1 |
Machine-room‑less freight elevator |
|
| 3 Building No. |
DT1 |
9 |
2 |
Machine-room‑less passenger elevator |
| DT2 |
2 |
1 |
Machine-room‑less freight elevator |
|
| 8 Building No. |
DT1 |
4 |
1 |
Machine-room freight elevator |
| DT2 |
5 |
1 |
Machine-room freight elevator |
|
| DT3 |
5 |
1 |
Machine-room freight elevator |
|
| DT4 |
5 |
1 |
Elevator for the machine room |
|
| 9 Building No.
|
DT1 |
5 |
1 |
Machine-room freight elevator |
| DT2 |
5 |
1 |
Machine-room freight elevator |
|
| DT3 |
5 |
1 |
Machine-room freight elevator |
|
| DT4 |
5 |
1 |
Machine-room freight elevator |
|
| DT5 |
5 |
1 |
Machine-room freight elevator |
|
| DT6 |
5 |
1 |
Elevator for the machine room |
|
| DT7 |
4 |
1 |
Elevator for the machine room |
|
| 10 Building No. |
DT1 |
9 |
1 |
Elevator for the machine room |
| DT2 |
2 |
1 |
Machine-room freight elevator |
|
| DT3 |
3 |
1 |
Machine-room freight elevator |
|
| DT4 |
3 |
1 |
Machine-room freight elevator |
|
| DT5 |
5 |
1 |
Machine-room freight elevator |
|
| DT6 |
3 |
1 |
Machine-room‑less freight elevator |
IV. Registration Instructions:
1 Units participating in the registration must submit the following documents: the business license of the legal entity, qualification certificates, the safety production license, a certificate of the legal representative or a letter of authorization from the legal representative, and copies of identification documents—four sets in total, with all copies stamped with the official seal of the unit—and must indicate the company’s registered capital.
2 Units participating in the registration must possess the relevant professional qualifications.
3 , Registration requires providing the organization’s contact person and contact information; the contact person must be the project leader or an designated business liaison, and please provide 12 Monthly social security certificate.
4 The tendering entity will review the qualification documents submitted by registered entities, giving priority to those with relevant project experience, and will conduct further discussions and on-site inspections with the shortlisted candidates.
5 , Beijing Minhai Biotechnology Co., Ltd. was established in 2004. Year is a wholly owned subsidiary of Shenzhen Kangtai Biological Products Co., Ltd. (a publicly listed company). For more information, please visit the company’s website.
V. Registration Process:
1 After registering by phone, bidders shall submit the relevant qualification documents to the registration email address.
2 Contact Information: Beijing Minhai Biotechnology Co., Ltd. (No. 35, Simiao Road, Bio‑Pharmaceutical Industry Base, Daxing District, Beijing) Number).
Contact persons: Mr. Hao, Ms. Fang, and Mr. Wu from the New Engineering Project Department; contact telephone: 010-57864910. , 57864916.
Registration email: mhzb@biominhai.com
VI. Registration Deadline : 2020 November 15 at 17:30.
Hereby announced!
Beijing Minhai Biotechnology Co., Ltd.
2020 October of the year 28th of the month

Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09